look under the rug, page-4

The problem is not of demand outstripping supply. In fact in spite of all the claims made at the presentation of a strong interest for Ropren, even at the current miniscule levels of production per month, Supply is outstripping Demand, and will continue to do so for atleast 9 months. Check graph released by them on page 23 of the last announcement.

Responsibly, a ramp up in production is usually initiated when the demand is nearing capacity.

With the way names have been liberally dropped of who is to sign the application, and how those listening responded to the proposal for expansion , this expansion seems more like information for investor consumption. The reality is with a product with so much interest, in the only market where it has been approved for Sales, there is No sale till date, not 1 single course.